DC-SIGN: Escape mechanism for pathogens

Nature Reviews Immunology

Volumn 3, Issue 9, 2003, Pages 697-709

  Van Kooyk, Yvette ^a   Geijtenbeek, Teunis B H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; TOLL LIKE RECEPTOR; CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN;

CELL FUNCTION; CELL SURVIVAL; CELLULAR IMMUNITY; DEFENSE MECHANISM; DENDRITIC CELL; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSURVEILLANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; ANTIGEN PRESENTATION; CHEMICAL STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; TUBERCULOSIS;

ANIMALS; ANTIGEN PRESENTATION; CELL ADHESION MOLECULES; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; LECTINS, C-TYPE; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CELL SURFACE; TUBERCULOSIS;

EID: 0141688292     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1182     Document Type: Review

References (142)

1. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. Mellman, I., Turley, S. J. & Steinman, R. M. Antigen processing for amateurs and professionals. Trends Cell. Biol. 8, 231-237 (1998).
3. H cell-polarizing signals. J. Immunol. 168, 1704-1709 (2002).
4. d'Ostiani, C. F. et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191, 1661-1674 (2000).
5. Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
6. Underhill, D. M. & Ozinsky, A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14, 103-110 (2002).
7. Thoma-Uszynski, S. et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291, 1544-1547 (2001).
8. Weis, W. I., Taylor, M. E. & Drickamer, K. The C-type lectin superfamily in the immune system. Immunol. Rev. 163, 19-34 (1998).
9. Akira, S. & Hemmi, H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85, 85-95 (2003).
10. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
11. Figdor, C. G., van Kooyk, Y. & Adema, G. J. C-type lectin receptors on dendritic cells and Langerhans cells. Nature Rev. Immunol. 2, 77-64 (2002).
12. Engering, A. et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168, 2118-2126 (2002).
13. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
14. Mahnke, K. et al. The dendritic cell receptor for endocytosis. DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell. Biol. 151, 673-684 (2000).
15. Geijtenbeek, T. B. H. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000). The first paper that identified DC-SIGN (dendritic cell (DC)-specific intercellular adhesion molecule-grabbing nonintegrin) as a DC specific C-type lectin that regulates DC-induced T-cell proliferation.
16. Dzionek, A. et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J. Exp. Med. 194, 1823-1834 (2001).
17. Willment, J. A., Gordon, S. & Brown, G. D. Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J. Biol. Chem. 276, 43818-43823 (2001).
18. Bates, E. E. et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163, 1973-1983 (1999).
19. Ryan, E. J. et al. Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4. J. Immunol. 169, 5638-5648 (2002).
20. Colonna, M., Samaridis, J. Angman, L. Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur. J. Immunol. 30, 697-704 (2000).
21. Valladeau, J. et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81 (2000).
22. Valladeau, J. et al. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J. Immunol. 167, 5767-5774 (2001).
23. Suzuki, N., Yamamoto, K., Toyoshima, S., Osawa, T. & Irimura, T. Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen. J. Immunol. 156, 128-135 (1996).
24. Kammerer, U. et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 162, 887-896 (2003).
25. Relloso, M. et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-β, and anti-inflammatory agents. J. Immunol. 168, 2634-2643 (2002).
26. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. & Lanzavecchia, A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393 (2001).
27. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869 (2001). This paper highlights DC-subset-specific expression of Toll-like receptors (TLRs) and tailored immune responses.
28. Liu, Y. J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-262 (2001).
29. Geijtenbeek, T. B. et al. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J. Biol. Chem. 277, 11314-11320 (2002).
30. 2+ -dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR. J. Biol. Chem. 269, 15505-15511 (1994).
31. Higashi, N. et al. Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages. Int. Immunol. 14, 545-554 (2002).
32. Higashi, N. et al. The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J. Bol. Chem. 277, 20586-20693 (2002).
33. Stambach, N. S. & Taylor, M. E. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiology 13, 401-410 (2003).
34. Frison, N. et al. Oigolysine-based oligosaccharide clusters: selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin. J. Biol. Chem. 278, 23922-23929 (2003).
35. Mitchell, D. A., Fadden, A. J. & Drickamer, K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276, 28939-28945 (2001).
36. Martinez-Pomares, L., Linehan, S. A., Taylor, P. R. & Gordon, S. Binding properties of the mannose receptor. Immunobiol. 204, 527-535 (2001).
37. Avrameas, A. et al. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur. J. Immunol. 26, 394-400 (1996).
38. Weis, W. I. & Drickamer, K. Trimeric structure of a C-type mannose-binding protein. Structure 2, 1227-1240 (1994).
39. Feinberg, H., Mitchell, D. A., Drickamer, K. & Weis, W. I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294, 2163-2166 (2001). This paper describes the mechanism of carbohydrate recognition by DC-SIGN.
40. Drickamer, K. Increasing diversity of animal lectin structures. Curr. Opin. Struct. Biol. 5, 612-616 (1995).
41. Kato, M. et al. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int. Immunol. 12, 1511-1519 (2000).
42. Engering, A., Geijtenbeek, T. B. & van Kooyk, Y. Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23, 480-485 (2002).
43. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001).
44. + T cell tolerance. J. Exp. Med. 196, 1627-1638 (2002). This paper shows that in vivo targeting of C-type lectin receptors might lead to tolerance induction.
45. Prigozy, T. I. et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6, 187-197 (1997).
46. Steinman, R. M. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100, 491-494 (2000).
47. Apostotopoulos, V. Pietersz, G. A. Gordon, S., Martinez-Pomares, L. & McKenzie, I. F. Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur. J. Immunol. 30, 1714-1723 (2000).
48. Apostolopoulos, V., Bames, N., Pietersz, G. A. & McKenzie, I. F. Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine 18, 3174-3184 (2000).
49. Lee, B. et al. Cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 75, 12028-12038 (2001).
50. Gordon, S. Pattern recognition receptors: doubling up for the innate immune response. Cell 111, 927-930 (2002). A hypothesis of the innate immune function of pattern recognition receptors expressed by DCs and macrophages is presented in this paper.
51. van Kooyk, Y. & Geijtenbeek, T. B. A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions. Immunol. Rev. 186, 47-56 (2002).
52. Monks, C. R., Freiberg, B. A. Kupfer, H., Sciaky, N. & Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86 (1998).
53. Grakoui, A. et al. The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221-227 (1999).
54. Dustin, M. L. and Chan, A. C. Signaling takes shape in the immune system. Cell 103, 283-294 (2000).
55. Lowe, J. B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186, 19-36 (2002).
56. Vestweber, D. Ligand-specificity of the selectins. J. Cell. Biochem. 61, 585-591 (1996).
57. de Fougerolles, A. R., Diamond, M. S. & Springer, T. A. Heterogenous glycosylation of ICAM-3 and lack of interaction with Mac-1 and p150,95. Eur. J. Immunol. 25, 1008-1012 (1995).
58. Funatsu, O. et al. Structural study of N-linked oligosaccharides of human intercellular adhesion molecule-3 (CD50). Eur. J. Biochem. 268, 1020-1029 (2001).
59. Daniels, M. A., Hogquist, K. A. & Jameson, S. C. Sweet 'n' sour: the impact of differential glycosytation on T cell responses. Nature Immunol. 3, 903-910 (2002).
60. Appelmelk, B. J. et al. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170, 1635-1639 (2003). This paper identifies the carbohydrate specificity of DC-SIGN and the identification of large variety of pathogens that interact with DC-SIGN.
61. Kogelberg, H., Montero, E., Bay, S., Lawson, A. M. & Feizi, T. Re-evaluation of monosaccharide binding property of recombinant soluble carbohydrate recognition domain of the natural killer cell receptor NKR-P1A. J. Biol. Chem. 274, 30335-30336 (1999).
62. Fukui, S., Feizi, T., Galustian, C., Lawson, A. M. & Chai, W. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nature Biotechnol. 20, 1011-1017 (2002).
63. Van Die, I. et al. The dendritic cell specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis-x. Glycobiology 13, 471-478 (2003).
64. Curtis, B. M., Scharnowske, S. & Watson, A. J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl Acad. Sci. USA 89, 8356-8360 (1992).
65. Geijtenbeek, T. B. H. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000). The first paper that described the molecular mechanism by which DCs transmit HIV-1.
66. Pohlmann, S., Baribaud, F. & Doms, R. W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 22, 643-646 (2001).
67. Sol-Foulon, N. et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16, 145-155 (2002).
68. Geijtenbeek, T. B. et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197, 7-17 (2003). This paper shows the mechanism by which mycobacteria escape immune surveillance by modulating TLR signalling through targeting DC-SIGN.
69. Colmenares, M., Puig-Kroger, A., Pello, O. M., Corbi, A. L. & Rivas, L. Dendritic cell (DQ-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277, 36766-36769 (2002).
70. Alvarez, C. P. et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841-6844 (2002).
71. Tailleux, L. et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121-127 (2003). This paper identifies DC-SIGN as a target for Mycobacterium tuberculosis.
72. Halary, F. et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17, 653-664 (2002).
73. Navarro-Sanchez, E. et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO rep. 4, 1-6 (2003).
74. Tassaneetrithep, B. et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823-829 (2003).
75. Gardner, J. P. et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl Acad. Sci. USA 100, 4498-4503 (2003).
76. Pohlmann, S. et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77, 4070-4080 (2003).
77. Lozach, P. Y. et al. DC-SIGN and L-SIGN are high-affinity binding receptors (or hepatitis C virus glycoprotein E2. J. Biol. Chem. 278, 20358-20366 (2003).
78. Simmons, G. et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305, 115-123 (2003).
79. Lue, J. et al. Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1. J. Virol. 76, 10299-10306 (2002).
80. Lin, C. L. et al. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192, 587-594 (2000).
81. Kwon, D. S., Gregorio, G., Bitton, N., Hendrickson, W. A. & Littman, D. R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16, 135-144 (2002). The first paper to identify that internalization of HIV-1 is required for the infection of T cells by DCs.
82. Hong, P. W. et al. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding. J. Virol. 76, 12855-12865 (2002).
83. Maeda, N. et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 278, 5513-5516 (2003).
84. Cambi, A. et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33, 532-538 (2003).
85. H2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J. Immunol. 163, 6712-6717 (1999).
86. + T cells. Science 257, 383-387 (1992).
87. Pope, M. et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398 (1994).
88. Jamesonm B. et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76, 1866-1875 (2002).
89. Kammerer, U. et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 162, 887-896 (2003).
90. - dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 33, 143-151 (2003).
91. Engering, A., Van Vliet, S. J., Geijtenbeek, T. B. & van Kooyk, Y. Subset of DC-SIGN- dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood 100, 1780-1786 (2002).
92. Geijtenbeek, T. B., Engering, A. & van Kooyk, Y. DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J. Leukoc. Biol. 71, 921-931 (2002).
93. Baribaud, F., Doms, R. W. & Pohlmam, S. The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? Expert Opin. Ther. Targets 6, 423-431 (2002).
94. Piguet, V. et al. Net-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes. Cell 97, 63-73 (1999).
95. Granelli-Piperno, A., Delgado, E., Finkel, V., Paxton, W. & Steinman, R. M. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72, 2733-2737 (1998).
96. Granelli-Piperno, A., Finkel, V., Delgado, E. & Steinman, R. M. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9, 21-29 (1999).
97. Nobile, C., Moris, A., Porrot, F., Sol-Foulon, N. & Schwartz, O. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. J. Virol. 77, 5313-5323 (2003).
98. Baribaud, F. et al. Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine dc-sign. J. Virol. 75, 10281-10289 (2001).
99. Geijtenbeek, T. B. et al. Rhesus macaque and chimpanzee DC-SIGN act as HIV/SIV gp120 trans-receptors, similar to human DC-SIGN. Immunol. Lett. 79, 101-107 (2001).
100. Yu Kimata, M. T. et al. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J. Virol. 76, 11827-11836 (2002).
101. Schwartz, A. J., Alvarez, X. & Lackner, A. A. Distribution and immunopnenotype of DC-SIGN-expressing cells in SIV-infected and uninfected macaques. AIDS Res. Hum. Retroviruses 18, 1021-1029 (2002).
102. Bobardt, M. D. et al. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18, 27-39 (2003). This report shows that other non-C-type lectins can function similarly to DC-SIGN as a trans-receptor for HIV-1.
103. Pohlmann, S. et al. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J. Virol. 75, 10523-10526 (2001).
104. Baribaud, F., Pohlmann, S. & Doms, R. W. The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. Virology 286, 1-6 (2001).
105. McDonald, D. et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300, 1295-1297 (2003). A recent paper showing the intracellular rearrangement of HIV-1 towards the immunologtcal synapse.
106. Patterson, S., Rae, A, Hockey, N., Gilmour, J. & Gotch, F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 75, 6710-6713 (2001).
107. Choi, Y. K. Fallert, B. A., Murphey-Corb, M. A. & Reinhart, T. A. Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo. Blood 101, 1684-1691 (2003).
108. Fong, L., Mengozzi, M., Abbey, N. W., Herndier, B. G. & Engleman, E. G. Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J. Virol. 76, 11033-11041 (2002).
109. Frank, I. et al. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J. Virol. 76, 2936-2951 (2002).
110. Raftery, M. J. et al. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15, 997-1009 (2001).
111. Andrews, D. M., Andoniou, C. E., Granucci, F., Ricciardi-Castagnoli, P. & Degli-Esposti, M. A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nature Immunol. 2, 1077-1084 (2001).
112. Turville, S. G. et al. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunol. 3, 975-983 (2002). This paper shows that potentially other C-type lectins are also involved in the capture of HIV-1-encoded envelope glycoprotein gp120.
113. Turville, S. G. et al. HIV gp120 receptors on human dendritic cells. Blood 98, 2482-2488 (2001).
114. Kavanagh, D. G. & Bhardwaj, N. A division of labor: DC subsets and HIV receptor diversity. Nature Immunol. 3, 891-893 (2002).
115. Weissman, D. & Fauci, A. S. Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clin. Microbiol. Rev. 10, 358-367 (1997).
116. Nguyen, D. G. & Hildreth, J. E. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33, 483-493 (2003).
117. Sanders, R. W. et al. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76, 7812-7821 (2002).
118. + T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. AIDS 16, 1319-1329 (2002).
119. Patel, M. et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 9, 167-174 (1993).
120. + cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72, 3623-3634 (1998).
121. Saphire, A. C., Bobardt, M. D., Zhang, Z., David, G. & Gallay, P. A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75, 9187-9200 (2001).
122. Callebaut, C., Nisole, S., Briand, J. P., Krust, B. & Hovanessian, A. G. Inhibition of HIV infection by the cytokine midkine. Virology 281, 248-264 (2001).
123. van Kooyk, Y., Appelmelk, B. & Geijtenbeek, T. B. A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance. Trends Mol. Med. 9, 153-159 (2003).
124. Nigou, J., Zelle-Rieser, C., Gilleron, M., Thumher, M. & Puzo, G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166, 7477-7485 (2001).
125. Soilleux, E. J. et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71, 445-457 (2002).
126. Kaufmann, S. H. & Schaible, U. E. A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J. Exp. Med. 197, 1-5 (2003).
127. Nigou, J., Vercellone, A. & Puzo, G. New structural insights into the molecular deciphering of mycobacterial lipoglycan binding to C-type lectins: lipoarabinomannan glycoform characterization and quantification by capillary electrophoresis at the subnanomole level. J. Mol. Bol. 299, 1353-1362 (2000).
128. Ehlers, M. R. & Daffe, M. Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol. 6, 328-335 (1998).
129. Schlesinger, L. S., Hull, S. R. & Kaufman, T. M. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152, 4070-4079 (1994).
130. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2, 675-680 (2001).
131. Chatterjee, D. & Khoo, K. H. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8, 113-120 (1998).
132. Sada, E., Brennan, P. J., Herrera, T. Torres, M. Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis. J. Clin. Microbiol. 28, 2587-2590 (1990).
133. Tsuji, S. et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect Immun. 68, 6883-6890 (2000).
134. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
135. Jiao, X. et al. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168, 1294-1301 (2002).
136. Fortsch, D., Rollinghoff, M. & Stenger, S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165, 978-987 (2000).
137. Grunebach, F., Weck, M. M., Reichert, J. & Brossart, P. Molecular and functional characterization of human Dectin-1. Exp. Hematol. 30, 1309-1315 (2002).
138. Brown, G. D. & Gordon, S. Immune recognition. A new receptor for β-glucans. Nature 413, 36-37 (2001).
139. Brown, G. D. et al. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197, 1119-1124 (2003). This paper, together with reference 138, shows that C-type lectins can modulate TLR signalling.
140. Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S. & Underhill, D. M. Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J. Exp. Med. 197, 1107-1117 (2003).
141. Geijtenbeek, T. B. et al. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100, 2908-2916 (2002).
142. Park, C. G. et al. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int. Immunol. 13, 1283-1290 (2001).